ESTRADIOL TRANSDERMAL

ESTRADIOL TRANSDERMAL was reported 46868 times

ESTRADIOL TRANSDERMAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SALPINGO-OOPHORECTOMY UNILATERAL 42 0.3818
1 ADHESIVE TAPE USE 85 0.2214
2 DERMAL ABSORPTION IMPAIRED 40 0.1429
3 BLOOD OESTROGEN DECREASED 85 0.1209
4 MENOPAUSAL SYMPTOMS 248 0.1064
5 SINUS RHYTHM 43 0.0986
6 BLOOD OESTROGEN INCREASED 53 0.0900
7 PRODUCT INEFFECTIVE 68 0.0865
8 SCHIZOAFFECTIVE DISORDER 153 0.0857
9 VULVOVAGINAL INJURY 47 0.0825
10 DEVICE ADHESION ISSUE 1249 0.0813
11 BREAST CANCER FEMALE 1708 0.0639
12 OESTROGEN RECEPTOR ASSAY POSITIVE 67 0.0591
13 SINUSITIS FUNGAL 47 0.0586
14 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 135 0.0568
15 PROGESTERONE RECEPTOR ASSAY POSITIVE 51 0.0546
16 PRODUCT DESIGN ISSUE 39 0.0545
17 PRODUCT PACKAGING ISSUE 473 0.0497
18 POSTMENOPAUSAL HAEMORRHAGE 127 0.0487
19 PRODUCT ADHESION ISSUE 1536 0.0429
20 EPIDERMAL NECROSIS 38 0.0390
21 VULVOVAGINAL DISCOMFORT 169 0.0382
22 EXPOSURE VIA DIRECT CONTACT 36 0.0379
23 APPLICATION SITE HYPERSENSITIVITY 44 0.0362
24 ATROPHIC VULVOVAGINITIS 26 0.0356
25 VULVOVAGINAL DRYNESS 115 0.0355
26 VULVOVAGINAL BURNING SENSATION 210 0.0344
27 VULVOVAGINAL ERYTHEMA 28 0.0335
28 PERIORBITAL PAIN 27 0.0319
29 FEMALE GENITAL TRACT FISTULA 54 0.0316
30 DRY AGE-RELATED MACULAR DEGENERATION 35 0.0315
31 BUTTERFLY RASH 29 0.0286
32 INCORRECT DOSE ADMINISTERED BY PRODUCT 45 0.0281
33 VULVOVAGINAL SWELLING 49 0.0268
34 OVARIAN HYPERSTIMULATION SYNDROME 61 0.0261
35 APPLICATION SITE RASH 346 0.0251
36 HORMONE LEVEL ABNORMAL 113 0.0231
37 SPUTUM INCREASED 50 0.0231
38 PRODUCT PACKAGING DIFFICULT TO OPEN 60 0.0230
39 APPLICATION SITE SCAR 28 0.0224
40 COLITIS MICROSCOPIC 105 0.0221
41 CHRONIC SINUSITIS 83 0.0221
42 VULVOVAGINAL PRURITUS 112 0.0221
43 VULVOVAGINAL PAIN 105 0.0218
44 APPLICATION SITE URTICARIA 47 0.0209
45 THERAPEUTIC PRODUCT INEFFECTIVE 80 0.0207
46 APPLICATION SITE IRRITATION 255 0.0205
47 BREAST TENDERNESS 149 0.0198
48 EMBOLISM VENOUS 60 0.0198
49 APPLICATION SITE DISCOMFORT 35 0.0195
50 APPLICATION SITE PRURITUS 441 0.0194
51 MENOPAUSE 49 0.0190
52 MACULOPATHY 67 0.0189
53 APPLICATION SITE INFLAMMATION 26 0.0188
54 DIASTOLIC DYSFUNCTION 58 0.0188
55 INFUSION SITE BRUISING 40 0.0185
56 RESPIRATORY SYMPTOM 52 0.0183
57 HYSTERECTOMY 158 0.0182
58 REBOUND ACID HYPERSECRETION 54 0.0178
59 SUSPECTED PRODUCT QUALITY ISSUE 32 0.0175
60 APPLICATION SITE ERYTHEMA 457 0.0174
61 INTERMENSTRUAL BLEEDING 96 0.0172
62 DEEP VEIN THROMBOSIS POSTOPERATIVE 34 0.0170
63 INVASIVE DUCTAL BREAST CARCINOMA 46 0.0169
64 INFUSION SITE DISCHARGE 29 0.0165
65 HOT FLUSH 1242 0.0165
66 EYELID PAIN 33 0.0162
67 BREAST CYST 28 0.0158
68 MENINGIOMA 238 0.0152
69 PRODUCT USE COMPLAINT 239 0.0152
70 HYPERPARATHYROIDISM SECONDARY 37 0.0148
71 SYMPTOM RECURRENCE 85 0.0142
72 APPLICATION SITE VESICLES 90 0.0139
73 NIPPLE PAIN 28 0.0137
74 INFUSION SITE PRURITUS 43 0.0136
75 PRODUCT SOLUBILITY ABNORMAL 68 0.0135
76 NEPHROGENIC ANAEMIA 62 0.0134
77 INFUSION SITE HAEMORRHAGE 44 0.0134
78 PRE-EXISTING CONDITION IMPROVED 83 0.0133
79 BREAST DISORDER 27 0.0132
80 HEPATIC NECROSIS 49 0.0130
81 NASAL POLYPS 63 0.0128
82 VAGINAL INFECTION 60 0.0127
83 APPLICATION SITE BURN 62 0.0126
84 BREAST ENLARGEMENT 41 0.0125
85 VULVOVAGINAL MYCOTIC INFECTION 49 0.0124
86 ENDOMETRIOSIS 57 0.0119
87 BREAST PAIN 126 0.0118
88 PRODUCT ADMINISTRATION INTERRUPTED 92 0.0117
89 NIGHT SWEATS 377 0.0117
90 DIVERTICULUM 81 0.0114
91 VAGINAL DISCHARGE 115 0.0114
92 DERMATITIS CONTACT 129 0.0113
93 BREAST SWELLING 30 0.0111
94 PRODUCT PHYSICAL ISSUE 222 0.0110
95 PRODUCT RESIDUE PRESENT 59 0.0109
96 ABNORMAL UTERINE BLEEDING 28 0.0109
97 SPINAL OSTEOARTHRITIS 95 0.0108
98 INTERVERTEBRAL DISC DEGENERATION 97 0.0105
99 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 353 0.0104
100 APPLICATION SITE REACTION 73 0.0104
101 UTERINE HAEMORRHAGE 44 0.0103
102 CLUMSINESS 28 0.0103
103 THYROID DISORDER 157 0.0102
104 DRUG LEVEL INCREASED 168 0.0101
105 TRICUSPID VALVE INCOMPETENCE 80 0.0101
106 SKIN REACTION 138 0.0098
107 RETINAL VEIN OCCLUSION 28 0.0097
108 MULTIPLE ALLERGIES 76 0.0097
109 APPLICATION SITE PAIN 213 0.0097
110 COLITIS ISCHAEMIC 65 0.0096
111 INFUSION SITE ERYTHEMA 81 0.0096
112 BRAIN FOG 148 0.0094
113 HAIR GROWTH ABNORMAL 65 0.0094
114 SPINAL FUSION SURGERY 38 0.0094
115 IMPAIRED GASTRIC EMPTYING 126 0.0092
116 NECK INJURY 27 0.0092
117 SLEEP APNOEA SYNDROME 175 0.0092
118 INFUSION SITE SWELLING 57 0.0090
119 LIGAMENT RUPTURE 40 0.0090
120 HIATUS HERNIA 117 0.0090
121 ASTHENOPIA 49 0.0089
122 DEVICE MALFUNCTION 623 0.0089
123 POOR QUALITY PRODUCT ADMINISTERED 93 0.0088
124 SNORING 33 0.0087
125 DYSPAREUNIA 40 0.0087
126 BREAST MASS 58 0.0086
127 DEVICE PHYSICAL PROPERTY ISSUE 66 0.0086
128 PRODUCT PHYSICAL CONSISTENCY ISSUE 47 0.0085
129 PRODUCT AVAILABILITY ISSUE 192 0.0084
130 DEVICE DEFECTIVE 144 0.0083
131 PRODUCT SUBSTITUTION ISSUE 478 0.0083
132 EMPHYSEMA 83 0.0082
133 SEASONAL ALLERGY 116 0.0082
134 MIGRAINE 782 0.0082
135 IRON DEFICIENCY ANAEMIA 75 0.0081
136 HYPERACUSIS 30 0.0081
137 FUNGAL INFECTION 266 0.0080
138 CANDIDA INFECTION 132 0.0078
139 ROSACEA 36 0.0077
140 TOXIC EPIDERMAL NECROLYSIS 117 0.0077
141 SPONDYLITIS 28 0.0077
142 VITAMIN D DEFICIENCY 75 0.0077
143 DIVERTICULITIS 213 0.0077
144 VAGINAL HAEMORRHAGE 333 0.0077
145 RESPIRATORY DEPRESSION 94 0.0077
146 COELIAC DISEASE 75 0.0076
147 OSTEOPENIA 116 0.0076
148 APPLICATION SITE DISCOLOURATION 31 0.0076
149 TONGUE DISCOMFORT 32 0.0075
150 OVARIAN CANCER 69 0.0075
151 EYE PAIN 420 0.0074
152 RHINITIS ALLERGIC 33 0.0074
153 SINUSITIS 749 0.0073
154 EXOSTOSIS 66 0.0072
155 RESTLESS LEGS SYNDROME 131 0.0072
156 FIBROMYALGIA 175 0.0072
157 HYPERTRIGLYCERIDAEMIA 42 0.0072
158 POST-TRAUMATIC STRESS DISORDER 48 0.0072
159 PRODUCT FORMULATION ISSUE 47 0.0071
160 APPLICATION SITE SWELLING 35 0.0070
161 MENISCUS INJURY 43 0.0070
162 BREAST CANCER METASTATIC 75 0.0070
163 POOR QUALITY SLEEP 150 0.0070
164 GLAUCOMA 134 0.0070
165 INFUSION SITE PAIN 89 0.0069
166 FOREIGN BODY SENSATION IN EYES 44 0.0069
167 ATTENTION DEFICIT HYPERACTIVITY DISORDER 29 0.0069
168 PRODUCT SIZE ISSUE 37 0.0069
169 UTERINE LEIOMYOMA 50 0.0068
170 IRRITABLE BOWEL SYNDROME 146 0.0068
171 SYNOVIAL CYST 31 0.0067
172 NEUROLOGICAL SYMPTOM 38 0.0066
173 BREAST CANCER 613 0.0066
174 INTERVERTEBRAL DISC DISORDER 28 0.0066
175 TENSION HEADACHE 28 0.0065
176 ORAL HERPES 127 0.0065
177 PSYCHIATRIC SYMPTOM 48 0.0065
178 OVARIAN CYST 65 0.0065
179 SYNOVITIS 117 0.0065
180 AUTOIMMUNE DISORDER 63 0.0065
181 PRODUCT ADMINISTRATION ERROR 130 0.0064
182 OSTEOPOROSIS 263 0.0064
183 BRONCHITIS 470 0.0063
184 GOITRE 26 0.0063
185 INCORRECT DRUG ADMINISTRATION RATE 27 0.0063
186 INCORRECT DOSE ADMINISTERED BY DEVICE 166 0.0063
187 DRY EYE 316 0.0063
188 OSTEOARTHRITIS 268 0.0063
189 TEARFULNESS 27 0.0063
190 MIDDLE INSOMNIA 117 0.0063
191 EYE IRRITATION 358 0.0062
192 LIGAMENT SPRAIN 61 0.0062
193 FACIAL PAIN 55 0.0062
194 ROTATOR CUFF SYNDROME 79 0.0061
195 SKIN ABRASION 29 0.0061
196 MICTURITION URGENCY 70 0.0061
197 EAR PAIN 119 0.0061
198 HEPATIC ENCEPHALOPATHY 57 0.0061
199 DECREASED INTEREST 36 0.0061
200 BURSITIS 74 0.0061
201 GLUCOSE TOLERANCE IMPAIRED 36 0.0061
202 CARPAL TUNNEL SYNDROME 85 0.0061
203 FOOT OPERATION 30 0.0061
204 FEELING DRUNK 45 0.0061
205 PRODUCT COLOUR ISSUE 31 0.0060
206 SCIATICA 96 0.0060
207 SKIN WARM 35 0.0060
208 CHRONIC KIDNEY DISEASE 455 0.0060
209 RASH PAPULAR 134 0.0060
210 SOMNAMBULISM 39 0.0059
211 CONCUSSION 46 0.0059
212 PRODUCT LABEL ISSUE 40 0.0059
213 GINGIVAL SWELLING 26 0.0059
214 OCULAR DISCOMFORT 66 0.0059
215 INSURANCE ISSUE 89 0.0058
216 VISUAL FIELD DEFECT 42 0.0058
217 SCOLIOSIS 36 0.0058
218 POOR QUALITY DEVICE USED 58 0.0058
219 TENDERNESS 60 0.0058
220 GASTROOESOPHAGEAL REFLUX DISEASE 463 0.0057
221 STREPTOCOCCAL INFECTION 32 0.0057
222 FOOT FRACTURE 109 0.0057
223 PRODUCT SUPPLY ISSUE 41 0.0057
224 IMPAIRED QUALITY OF LIFE 82 0.0057
225 HYPERLIPIDAEMIA 68 0.0057
226 TEMPERATURE INTOLERANCE 58 0.0056
227 VITAMIN D DECREASED 48 0.0056
228 SCAR 96 0.0056
229 SPINAL OPERATION 69 0.0056
230 AFFECTIVE DISORDER 44 0.0056
231 NEURALGIA 136 0.0056
232 PRODUCT QUALITY ISSUE 753 0.0055
233 SQUAMOUS CELL CARCINOMA 52 0.0055
234 NERVE INJURY 61 0.0055
235 PARAESTHESIA ORAL 79 0.0055
236 CRYING 199 0.0055
237 SINUS DISORDER 108 0.0054
238 ANAL INCONTINENCE 49 0.0054
239 PRODUCT ODOUR ABNORMAL 57 0.0054
240 INTERVERTEBRAL DISC PROTRUSION 118 0.0054
241 PERIORBITAL OEDEMA 28 0.0054
242 CYSTITIS 171 0.0054
243 BODY HEIGHT DECREASED 57 0.0053
244 UPPER RESPIRATORY TRACT INFECTION 246 0.0053
245 PHOTOPHOBIA 100 0.0053
246 FORMICATION 37 0.0053
247 TOOTH INFECTION 70 0.0053
248 LOW DENSITY LIPOPROTEIN INCREASED 41 0.0053
249 VITREOUS FLOATERS 52 0.0053
250 RENAL PAIN 56 0.0053
251 LIMB DISCOMFORT 163 0.0053
252 INITIAL INSOMNIA 54 0.0053
253 CARDIAC FLUTTER 34 0.0053
254 SWELLING OF EYELID 33 0.0053
255 SINUS CONGESTION 71 0.0052
256 TINNITUS 241 0.0052
257 ABDOMINAL DISTENSION 547 0.0052
258 BLADDER DISORDER 52 0.0052
259 ABDOMINAL TENDERNESS 26 0.0052
260 HYPERAESTHESIA 43 0.0052
261 THERMAL BURN 37 0.0052
262 OBSTRUCTIVE AIRWAYS DISORDER 58 0.0052
263 NERVE COMPRESSION 48 0.0052
264 SKIN LACERATION 56 0.0051
265 DEVICE USE ISSUE 90 0.0051
266 DISEASE RECURRENCE 244 0.0051
267 HEPATIC CIRRHOSIS 96 0.0051
268 INCREASED TENDENCY TO BRUISE 47 0.0051
269 SLEEP DISORDER 360 0.0051
270 UPPER-AIRWAY COUGH SYNDROME 42 0.0051
271 NECK PAIN 284 0.0051
272 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 33 0.0051
273 HERPES SIMPLEX 33 0.0051
274 FRUSTRATION TOLERANCE DECREASED 41 0.0051
275 PALPITATIONS 591 0.0050
276 GASTROINTESTINAL MOTILITY DISORDER 27 0.0050
277 INSOMNIA 1342 0.0050
278 ELECTROCARDIOGRAM QT PROLONGED 181 0.0050
279 DYSGRAPHIA 33 0.0050
280 HEAVY MENSTRUAL BLEEDING 45 0.0050
281 DEPRESSED MOOD 264 0.0050
282 LIQUID PRODUCT PHYSICAL ISSUE 36 0.0049
283 RESPIRATORY TRACT CONGESTION 78 0.0049
284 BURNING SENSATION 344 0.0049
285 EAR DISCOMFORT 50 0.0049
286 LIP SWELLING 162 0.0049
287 SPINAL DISORDER 46 0.0049
288 MOUTH SWELLING 28 0.0048
289 ANKLE FRACTURE 75 0.0048
290 URINARY INCONTINENCE 143 0.0048
291 PRODUCT LEAKAGE 27 0.0048
292 SQUAMOUS CELL CARCINOMA OF SKIN 29 0.0048
293 MANIA 79 0.0048
294 MOOD SWINGS 153 0.0048
295 DEPRESSION 1091 0.0048
296 NASAL DRYNESS 30 0.0048
297 DRUG-INDUCED LIVER INJURY 150 0.0048
298 END STAGE RENAL DISEASE 87 0.0048
299 HAEMORRHOIDS 93 0.0048
300 FEELING HOT 291 0.0047
301 PHOTOPSIA 30 0.0047
302 POLYP 31 0.0047
303 DRUG EFFECT LESS THAN EXPECTED 70 0.0047
304 FEELING JITTERY 90 0.0047
305 BLOOD POTASSIUM DECREASED 142 0.0047
306 PANIC ATTACK 172 0.0047
307 TOOTH FRACTURE 52 0.0047
308 SMALL INTESTINAL OBSTRUCTION 58 0.0047
309 URINARY TRACT INFECTION 801 0.0047
310 NAIL DISORDER 41 0.0047
311 WEIGHT FLUCTUATION 49 0.0047
312 FEELING ABNORMAL 1119 0.0047
313 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 85 0.0046
314 ABNORMAL FAECES 38 0.0046
315 PSORIATIC ARTHROPATHY 188 0.0046
316 MUSCLE STRAIN 40 0.0046
317 THERAPEUTIC PRODUCT EFFECT DECREASED 207 0.0046
318 EYE DISCHARGE 48 0.0046
319 HYPERHIDROSIS 595 0.0046
320 ORAL DISCOMFORT 64 0.0046
321 HEADACHE 2880 0.0046
322 ECONOMIC PROBLEM 69 0.0045
323 DEVICE ISSUE 408 0.0045
324 INCONTINENCE 48 0.0045
325 JOINT DISLOCATION 48 0.0045
326 IMPAIRED WORK ABILITY 97 0.0045
327 MAJOR DEPRESSION 33 0.0045
328 PAROSMIA 34 0.0045
329 BACK INJURY 49 0.0045
330 ONYCHOCLASIS 31 0.0045
331 HYPERPROLACTINAEMIA 29 0.0045
332 MUSCLE SPASMS 819 0.0045
333 DISCOMFORT 272 0.0045
334 TENDON RUPTURE 55 0.0045
335 GASTROINTESTINAL PAIN 49 0.0044
336 CONTUSION 428 0.0044
337 POSTOPERATIVE WOUND INFECTION 30 0.0044
338 WEIGHT INCREASED 994 0.0044
339 TENSION 27 0.0044
340 PHOTOSENSITIVITY REACTION 73 0.0044
341 NASAL DISCOMFORT 35 0.0044
342 PRODUCT DOSE OMISSION IN ERROR 125 0.0044
343 VERTIGO 269 0.0044
344 ORAL CANDIDIASIS 58 0.0044
345 MUSCLE TIGHTNESS 71 0.0044
346 BLOOD IRON DECREASED 52 0.0044
347 HAND FRACTURE 31 0.0044
348 DRY MOUTH 355 0.0044
349 ANXIETY 1240 0.0044
350 HEAD DISCOMFORT 77 0.0043
351 PARAESTHESIA 684 0.0043
352 MENSTRUAL DISORDER 36 0.0043
353 SWELLING FACE 283 0.0043
354 GASTRITIS 114 0.0043
355 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 208 0.0043
356 GRIP STRENGTH DECREASED 38 0.0043
357 TOOTHACHE 78 0.0043
358 SUICIDAL IDEATION 393 0.0043
359 GINGIVAL PAIN 34 0.0043
360 PRODUCT DOSE OMISSION ISSUE 1256 0.0043
361 CYST 53 0.0043
362 ABORTION SPONTANEOUS 170 0.0042
363 MUSCULOSKELETAL DISCOMFORT 73 0.0042
364 PELVIC PAIN 77 0.0042
365 RASH ERYTHEMATOUS 202 0.0042
366 MUSCLE INJURY 35 0.0042
367 BALANCE DISORDER 365 0.0042
368 ILLNESS 434 0.0042
369 NOCTURIA 51 0.0042
370 MALNUTRITION 47 0.0042
371 ASTHMA 474 0.0042
372 EYE SWELLING 156 0.0042
373 FEEDING DISORDER 85 0.0042
374 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 848 0.0042
375 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 71 0.0042
376 OROPHARYNGEAL PAIN 387 0.0042
377 SENSORY DISTURBANCE 67 0.0042
378 EYE INFECTION 47 0.0042
379 SWOLLEN TONGUE 130 0.0042
380 IRRITABILITY 250 0.0042
381 DISTURBANCE IN ATTENTION 224 0.0041
382 METASTASES TO LYMPH NODES 28 0.0041
383 FOOD ALLERGY 32 0.0041
384 VENTRICULAR EXTRASYSTOLES 43 0.0041
385 INTENTIONAL DOSE OMISSION 118 0.0041
386 IMPAIRED DRIVING ABILITY 47 0.0041
387 ALOPECIA 808 0.0041
388 GASTROENTERITIS 60 0.0041
389 DYSPEPSIA 404 0.0041
390 EYE MOVEMENT DISORDER 28 0.0041
391 PHARYNGEAL SWELLING 40 0.0041
392 RENAL TUBULAR NECROSIS 40 0.0041
393 RASH PRURITIC 221 0.0041
394 SURGERY 239 0.0041
395 HYPERTHYROIDISM 59 0.0041
396 MOOD ALTERED 111 0.0041
397 TENDONITIS 63 0.0041
398 ARTHRITIS 320 0.0041
399 THERAPY CHANGE 40 0.0041
400 KNEE OPERATION 40 0.0041
401 POST PROCEDURAL INFECTION 33 0.0041
402 PRURITUS 1558 0.0041
403 LACRIMATION INCREASED 122 0.0040
404 DRUG INTERACTION 640 0.0040
405 SCAB 46 0.0040
406 CHEST DISCOMFORT 413 0.0040
407 BLOOD CHOLESTEROL INCREASED 188 0.0040
408 CHOLECYSTECTOMY 46 0.0040
409 COVID-19 705 0.0040
410 SKIN INFECTION 45 0.0040
411 NEPHROLITHIASIS 183 0.0040
412 PRODUCT DISTRIBUTION ISSUE 37 0.0040
413 EAR INFECTION 106 0.0040
414 CONTRAINDICATED PRODUCT ADMINISTERED 120 0.0040
415 COORDINATION ABNORMAL 55 0.0039
416 MUSCULOSKELETAL CHEST PAIN 61 0.0039
417 ABDOMINAL DISCOMFORT 661 0.0039
418 LIMB INJURY 107 0.0039
419 DRY THROAT 40 0.0039
420 ARTHRALGIA 1634 0.0039
421 HYPERSENSITIVITY 729 0.0039
422 PAIN IN JAW 111 0.0039
423 THINKING ABNORMAL 73 0.0039
424 DYSPHONIA 229 0.0039
425 SKIN IRRITATION 179 0.0039
426 FLUSHING 396 0.0039
427 HELICOBACTER INFECTION 40 0.0039
428 GAIT INABILITY 130 0.0039
429 SUNBURN 29 0.0039
430 INFLUENZA LIKE ILLNESS 320 0.0039
431 JOINT INJURY 83 0.0039
432 VISION BLURRED 533 0.0039
433 URTICARIA 650 0.0039
434 PANIC REACTION 28 0.0039
435 FEELING COLD 108 0.0039
436 ANGER 131 0.0039
437 THIRST 69 0.0039
438 NERVOUSNESS 201 0.0038
439 BACK PAIN 892 0.0038
440 THERAPEUTIC RESPONSE UNEXPECTED 172 0.0038
441 DRUG LEVEL DECREASED 39 0.0038
442 DERMATITIS ATOPIC 202 0.0038
443 KIDNEY INFECTION 75 0.0038
444 DIPLOPIA 99 0.0038
445 HYPOAESTHESIA 570 0.0038
446 HEART RATE INCREASED 377 0.0038
447 LOWER LIMB FRACTURE 73 0.0038
448 TASTE DISORDER 77 0.0038
449 POLLAKIURIA 158 0.0038
450 RASH MACULAR 132 0.0038
451 MACULAR DEGENERATION 45 0.0038
452 AMNESIA 245 0.0038
453 ECZEMA 197 0.0038
454 MEMORY IMPAIRMENT 517 0.0038
455 FACIAL PARALYSIS 32 0.0038
456 AFFECT LABILITY 36 0.0037
457 OBSESSIVE-COMPULSIVE DISORDER 30 0.0037
458 BONE DISORDER 68 0.0037
459 HEPATOTOXICITY 83 0.0037
460 QUALITY OF LIFE DECREASED 50 0.0037
461 NASAL CONGESTION 218 0.0037
462 INJECTION SITE URTICARIA 91 0.0037
463 NIGHTMARE 128 0.0037
464 PHARYNGITIS STREPTOCOCCAL 40 0.0037
465 PRODUCT PRESCRIBING ERROR 88 0.0037
466 CHOLELITHIASIS 121 0.0037
467 IMMUNODEFICIENCY 55 0.0037
468 FATIGUE 2870 0.0037
469 PAIN IN EXTREMITY 1086 0.0037
470 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 172 0.0037
471 BIPOLAR DISORDER 40 0.0037
472 BLOOD TRIGLYCERIDES INCREASED 65 0.0037
473 BLISTER 206 0.0037
474 MUSCULAR WEAKNESS 415 0.0036
475 BLOOD CALCIUM INCREASED 32 0.0036
476 ARTHROPOD BITE 27 0.0036
477 PHARYNGEAL OEDEMA 56 0.0036
478 BONE PAIN 213 0.0036
479 VIRAL INFECTION 121 0.0036
480 APATHY 53 0.0036
481 NAUSEA 2875 0.0036
482 EATING DISORDER 77 0.0036
483 DENTAL CARIES 40 0.0036
484 DEVICE DELIVERY SYSTEM ISSUE 99 0.0036
485 DIZZINESS POSTURAL 35 0.0036
486 SECRETION DISCHARGE 45 0.0036
487 THROAT IRRITATION 161 0.0036
488 JOINT STIFFNESS 94 0.0036
489 HEPATIC ENZYME INCREASED 244 0.0036
490 GLOSSODYNIA 80 0.0036
491 SKIN SWELLING 31 0.0036
492 DRUG INTOLERANCE 345 0.0036
493 GASTROINTESTINAL INFECTION 32 0.0036
494 PERIPHERAL COLDNESS 49 0.0036
495 BACK DISORDER 58 0.0036
496 UPPER LIMB FRACTURE 71 0.0036
497 MUSCLE ATROPHY 45 0.0035
498 SYSTEMIC LUPUS ERYTHEMATOSUS 126 0.0035
499 PRODUCT TASTE ABNORMAL 48 0.0035
500 GASTROENTERITIS VIRAL 64 0.0035
501 APHASIA 107 0.0035
502 PRODUCT USE ISSUE 665 0.0035
503 BLOOD PRESSURE SYSTOLIC INCREASED 69 0.0035
504 RESPIRATORY TRACT INFECTION 92 0.0035
505 DIARRHOEA HAEMORRHAGIC 33 0.0035
506 JOINT SWELLING 426 0.0035
507 TRANSIENT ISCHAEMIC ATTACK 119 0.0035
508 HYPERSOMNIA 101 0.0035
509 RASH 1535 0.0035
510 INJECTION SITE RASH 108 0.0035
511 FOOT DEFORMITY 39 0.0035
512 KNEE ARTHROPLASTY 74 0.0035
513 SCRATCH 37 0.0035
514 SPINAL COMPRESSION FRACTURE 29 0.0035
515 MENTAL IMPAIRMENT 85 0.0035
516 EMOTIONAL DISORDER 108 0.0035
517 BLOOD PRESSURE INCREASED 535 0.0035
518 DISABILITY 69 0.0035
519 POST PROCEDURAL COMPLICATION 67 0.0035
520 PRODUCT PRESCRIBING ISSUE 76 0.0035
521 MOVEMENT DISORDER 112 0.0035
522 THERAPY CESSATION 179 0.0035
523 OEDEMA 189 0.0035
524 SWELLING 326 0.0035
525 MYALGIA 592 0.0035
526 HEAD INJURY 110 0.0035
527 GASTRIC DISORDER 119 0.0035
528 PELVIC FRACTURE 27 0.0035
529 PERIPHERAL SWELLING 534 0.0035
530 MUSCLE DISORDER 28 0.0035
531 DIZZINESS 1724 0.0035
532 ABDOMINAL PAIN UPPER 711 0.0034
533 SKIN DISORDER 115 0.0034
534 EYE HAEMORRHAGE 46 0.0034
535 DYSGEUSIA 256 0.0034
536 MITRAL VALVE INCOMPETENCE 39 0.0034
537 EYELID PTOSIS 35 0.0034
538 IMPAIRED HEALING 113 0.0034
539 APHONIA 48 0.0034
540 GASTROINTESTINAL DISORDER 308 0.0034
541 THERAPEUTIC RESPONSE SHORTENED 114 0.0034
542 ACTIVITIES OF DAILY LIVING IMPAIRED 68 0.0034
543 SKIN FISSURES 67 0.0034
544 DYSPNOEA EXERTIONAL 129 0.0034
545 PRODUCT USE IN UNAPPROVED INDICATION 848 0.0034
546 WRIST FRACTURE 41 0.0034
547 C-REACTIVE PROTEIN INCREASED 124 0.0034
548 CONSTIPATION 743 0.0034
549 WITHDRAWAL SYNDROME 143 0.0034
550 RIB FRACTURE 70 0.0034
551 DYSMENORRHOEA 45 0.0034
552 WHEEZING 201 0.0034
553 RHINORRHOEA 219 0.0034
554 PAIN 2079 0.0034
555 MUSCLE TWITCHING 78 0.0034
556 HERPES ZOSTER 194 0.0034
557 CHEST PAIN 625 0.0034
558 SPUTUM DISCOLOURED 32 0.0034
559 ROAD TRAFFIC ACCIDENT 141 0.0034
560 BLOOD PRESSURE ABNORMAL 67 0.0034
561 CHROMATURIA 76 0.0034
562 THROAT TIGHTNESS 91 0.0034
563 HAIR TEXTURE ABNORMAL 45 0.0034
564 COGNITIVE DISORDER 157 0.0034
565 ABDOMINAL PAIN 782 0.0034
566 TUBULOINTERSTITIAL NEPHRITIS 63 0.0034
567 MYDRIASIS 43 0.0033
568 PHARMACEUTICAL PRODUCT COMPLAINT 87 0.0033
569 ORAL PAIN 75 0.0033
570 COLD SWEAT 59 0.0033
571 GAIT DISTURBANCE 639 0.0033
572 LOSS OF LIBIDO 30 0.0033
573 FLATULENCE 189 0.0033
574 ABNORMAL DREAMS 92 0.0033
575 EXPOSURE VIA SKIN CONTACT 86 0.0033
576 ANOSMIA 48 0.0033
577 FLANK PAIN 31 0.0033
578 INJECTION SITE PRURITUS 221 0.0033
579 SALIVARY HYPERSECRETION 33 0.0033
580 PANCREATITIS ACUTE 74 0.0033
581 MASS 46 0.0033
582 OCULAR HYPERAEMIA 156 0.0033
583 FLUID RETENTION 167 0.0033
584 HAIR DISORDER 27 0.0033
585 HEART RATE IRREGULAR 74 0.0033
586 LOCAL SWELLING 57 0.0033
587 ERUCTATION 63 0.0033
588 MUSCLE SPASTICITY 40 0.0033
589 CLOSTRIDIUM DIFFICILE INFECTION 71 0.0032
590 HYPOAESTHESIA ORAL 49 0.0032
591 LYMPHADENOPATHY 115 0.0032
592 TREMOR 539 0.0032
593 PROCEDURAL PAIN 90 0.0032
594 CATARACT 193 0.0032
595 TOOTH ABSCESS 33 0.0032
596 COUGH 908 0.0032
597 BLOOD SODIUM DECREASED 61 0.0032
598 PHARYNGITIS 40 0.0032
599 LETHARGY 185 0.0032
600 HYPERCHOLESTEROLAEMIA 31 0.0032
601 SNEEZING 72 0.0032
602 INJECTION SITE WARMTH 66 0.0032
603 COLITIS 121 0.0032
604 RHEUMATOID ARTHRITIS 362 0.0032
605 MUSCULOSKELETAL PAIN 167 0.0032
606 DEPRESSED LEVEL OF CONSCIOUSNESS 126 0.0032
607 OEDEMA PERIPHERAL 388 0.0032
608 HYPERTENSION 671 0.0032
609 HEPATIC STEATOSIS 59 0.0032
610 HUNGER 44 0.0032
611 SKIN CANCER 68 0.0032
612 DISORIENTATION 125 0.0032
613 NASOPHARYNGITIS 581 0.0031
614 INCREASED APPETITE 60 0.0031
615 INTENTIONAL PRODUCT USE ISSUE 275 0.0031
616 MULTIPLE SCLEROSIS 150 0.0031
617 BLOOD MAGNESIUM DECREASED 27 0.0031
618 CHOKING 61 0.0031
619 ARTHROPATHY 173 0.0031
620 ANKYLOSING SPONDYLITIS 41 0.0031
621 HEART RATE DECREASED 109 0.0031
622 POOR VENOUS ACCESS 32 0.0031
623 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 53 0.0031
624 WEIGHT DECREASED 863 0.0031
625 MOUTH ULCERATION 65 0.0031
626 LOWER RESPIRATORY TRACT INFECTION 140 0.0031
627 HIP ARTHROPLASTY 47 0.0031
628 RENAL INJURY 91 0.0031
629 PULMONARY EMBOLISM 291 0.0031
630 BLOOD TEST ABNORMAL 43 0.0031
631 PRESYNCOPE 74 0.0030
632 BLOOD PRESSURE FLUCTUATION 73 0.0030
633 INFLUENZA 339 0.0030
634 HYPOTHYROIDISM 97 0.0030
635 EYE PRURITUS 102 0.0030
636 HEPATOCELLULAR INJURY 43 0.0030
637 PULMONARY THROMBOSIS 33 0.0030
638 DIARRHOEA 1953 0.0030
639 PRODUCT DOSE OMISSION 197 0.0030
640 CELLULITIS 152 0.0030
641 CONDITION AGGRAVATED 914 0.0030
642 ABDOMINAL PAIN LOWER 76 0.0030
643 PRODUCTIVE COUGH 143 0.0030
644 PLATELET COUNT INCREASED 39 0.0030
645 SPINAL PAIN 35 0.0030
646 CHILLS 349 0.0030
647 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 536 0.0030
648 GALLBLADDER DISORDER 53 0.0030
649 INJECTION SITE ERYTHEMA 368 0.0030
650 AGEUSIA 74 0.0030
651 DECREASED ACTIVITY 32 0.0030
652 INFLAMMATION 153 0.0030
653 PSORIASIS 387 0.0030
654 MUSCULOSKELETAL STIFFNESS 259 0.0030
655 OBESITY 47 0.0029
656 DYSARTHRIA 111 0.0029
657 BASAL CELL CARCINOMA 46 0.0029
658 GASTRIC ULCER 56 0.0029
659 INJECTION SITE BRUISING 235 0.0029
660 VISUAL IMPAIRMENT 365 0.0029
661 INTESTINAL OBSTRUCTION 111 0.0029
662 FALL 979 0.0029
663 THERAPY INTERRUPTED 210 0.0029
664 THERAPY NON-RESPONDER 132 0.0029
665 INABILITY TO AFFORD MEDICATION 29 0.0029
666 EYE DISORDER 96 0.0029
667 PRURITUS GENERALISED 63 0.0029
668 DYSURIA 107 0.0029
669 DEVICE DIFFICULT TO USE 192 0.0029
670 DRUG INEFFECTIVE 3822 0.0029
671 DEEP VEIN THROMBOSIS 188 0.0029
672 PRODUCT DISPENSING ERROR 63 0.0029
673 TOOTH EXTRACTION 36 0.0029
674 SPEECH DISORDER 151 0.0029
675 LACERATION 27 0.0029
676 INCORRECT DOSE ADMINISTERED 655 0.0029
677 FOLLICULITIS 30 0.0029
678 VOMITING 1344 0.0029
679 MALAISE 1253 0.0029
680 CONJUNCTIVITIS 53 0.0029
681 LOCALISED INFECTION 69 0.0029
682 STAPHYLOCOCCAL INFECTION 94 0.0028
683 BODY TEMPERATURE DECREASED 28 0.0028
684 MADAROSIS 33 0.0028
685 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 156 0.0028
686 BODY TEMPERATURE INCREASED 58 0.0028
687 DYSSTASIA 83 0.0028
688 PARANOIA 49 0.0028
689 BACTERIAL INFECTION 53 0.0028
690 NEUROPATHY PERIPHERAL 270 0.0028
691 BRAIN NEOPLASM 26 0.0028
692 SKIN DISCOLOURATION 130 0.0028
693 BLOOD THYROID STIMULATING HORMONE INCREASED 26 0.0028
694 FEAR 76 0.0028
695 PAIN OF SKIN 76 0.0028
696 SUPRAVENTRICULAR TACHYCARDIA 27 0.0028
697 DEVICE BREAKAGE 114 0.0028
698 MULTIPLE SCLEROSIS RELAPSE 192 0.0028
699 ASTHENIA 1053 0.0028
700 DYSKINESIA 113 0.0028
701 UNEVALUABLE EVENT 210 0.0028
702 HEMIPARESIS 47 0.0028
703 HAEMATOCRIT DECREASED 55 0.0028
704 MATERNAL EXPOSURE DURING PREGNANCY 247 0.0028
705 RETCHING 59 0.0028
706 INJECTION SITE REACTION 190 0.0028
707 JOINT RANGE OF MOTION DECREASED 37 0.0028
708 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 196 0.0028
709 PANCREATITIS 145 0.0027
710 MOBILITY DECREASED 197 0.0027
711 BLOOD URINE PRESENT 52 0.0027
712 OFF LABEL USE 2394 0.0027
713 DRUG EFFECT DECREASED 147 0.0027
714 GENERALISED TONIC-CLONIC SEIZURE 45 0.0027
715 LIVER FUNCTION TEST ABNORMAL 79 0.0027
716 COVID-19 PNEUMONIA 32 0.0027
717 EXPIRED PRODUCT ADMINISTERED 90 0.0027
718 RESPIRATORY DISORDER 81 0.0027
719 FREQUENT BOWEL MOVEMENTS 73 0.0027
720 SOMNOLENCE 544 0.0027
721 DYSPNOEA 1525 0.0027
722 PULMONARY MASS 40 0.0027
723 WRONG TECHNIQUE IN DRUG USAGE PROCESS 97 0.0027
724 SKIN EXFOLIATION 225 0.0027
725 SKIN LESION 73 0.0027
726 ANAPHYLACTIC REACTION 147 0.0027
727 INJECTION SITE PAIN 815 0.0027
728 OESOPHAGITIS 29 0.0027
729 TOOTH DISORDER 59 0.0027
730 SARS-COV-2 TEST POSITIVE 35 0.0026
731 ULCER 42 0.0026
732 HERNIA 51 0.0026
733 SKIN HAEMORRHAGE 39 0.0026
734 MUSCULOSKELETAL DISORDER 50 0.0026
735 RASH GENERALISED 68 0.0026
736 DERMATITIS 55 0.0026
737 DEHYDRATION 348 0.0026
738 RECTAL HAEMORRHAGE 112 0.0026
739 NODULE 34 0.0026
740 INJECTION SITE IRRITATION 33 0.0026
741 HYPERCALCAEMIA 32 0.0026
742 WHITE BLOOD CELL COUNT INCREASED 99 0.0026
743 PSYCHOTIC DISORDER 76 0.0026
744 HAIR COLOUR CHANGES 32 0.0026
745 RESTLESSNESS 94 0.0026
746 SEROTONIN SYNDROME 49 0.0025
747 SPINAL FRACTURE 51 0.0025
748 DERMATITIS ALLERGIC 32 0.0025
749 WOUND 71 0.0025
750 DRY SKIN 339 0.0025
751 EUPHORIC MOOD 26 0.0025
752 INFECTION 367 0.0025
753 INJECTION SITE SWELLING 194 0.0025
754 ERYTHEMA 519 0.0025
755 TYPE 2 DIABETES MELLITUS 85 0.0025
756 ACUTE KIDNEY INJURY 385 0.0025
757 RENAL FAILURE 334 0.0025
758 IMMUNE SYSTEM DISORDER 33 0.0025
759 NERVOUS SYSTEM DISORDER 78 0.0025
760 ADVERSE DRUG REACTION 224 0.0025
761 FAECES DISCOLOURED 54 0.0025
762 CENTRAL NERVOUS SYSTEM LESION 34 0.0025
763 ADRENAL INSUFFICIENCY 30 0.0025
764 LIVER FUNCTION TEST INCREASED 53 0.0025
765 INJECTION SITE INDURATION 32 0.0025
766 WOUND INFECTION 27 0.0025
767 GLYCOSYLATED HAEMOGLOBIN INCREASED 62 0.0025
768 LOSS OF CONSCIOUSNESS 313 0.0024
769 CHOLECYSTITIS 29 0.0024
770 DYSPHAGIA 231 0.0024
771 GINGIVAL BLEEDING 33 0.0024
772 ILEUS 30 0.0024
773 ADVERSE REACTION 32 0.0024
774 ISCHAEMIC STROKE 43 0.0024
775 DEAFNESS 63 0.0024
776 PRODUCT COMPLAINT 61 0.0024
777 NEEDLE ISSUE 70 0.0024
778 BLOOD CALCIUM DECREASED 27 0.0024
779 AGITATION 176 0.0024
780 STOMATITIS 145 0.0024
781 HALLUCINATION 180 0.0024
782 HYPOACUSIS 102 0.0024
783 INJECTION SITE MASS 87 0.0024
784 PSYCHOMOTOR HYPERACTIVITY 39 0.0023
785 HYPOPHAGIA 60 0.0023
786 SKIN BURNING SENSATION 168 0.0023
787 MENTAL DISORDER 102 0.0023
788 HYPERTENSIVE CRISIS 26 0.0023
789 SINUS TACHYCARDIA 33 0.0023
790 NO ADVERSE EVENT 421 0.0023
791 MEDICATION ERROR 129 0.0023
792 LYMPHOCYTE COUNT DECREASED 41 0.0023
793 INCORRECT PRODUCT ADMINISTRATION DURATION 50 0.0023
794 ABASIA 57 0.0023
795 PRESCRIBED UNDERDOSE 46 0.0023
796 ANHEDONIA 60 0.0023
797 SKIN ULCER 59 0.0023
798 INFUSION RELATED REACTION 151 0.0023
799 UNDERDOSE 166 0.0023
800 PERICARDITIS 38 0.0023
801 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 118 0.0023
802 TREATMENT FAILURE 187 0.0023
803 BLOOD ALKALINE PHOSPHATASE INCREASED 56 0.0023
804 DECREASED APPETITE 521 0.0022
805 ANGINA PECTORIS 64 0.0022
806 HAEMORRHAGE 233 0.0022
807 HAND DEFORMITY 29 0.0022
808 OSTEOMYELITIS 40 0.0022
809 PNEUMONIA 714 0.0022
810 INJECTION SITE HAEMATOMA 32 0.0022
811 GLOMERULAR FILTRATION RATE DECREASED 27 0.0022
812 ABSCESS 35 0.0022
813 INTENTIONAL PRODUCT MISUSE 192 0.0022
814 MULTIPLE FRACTURES 36 0.0022
815 TREATMENT NONCOMPLIANCE 119 0.0022
816 PRESCRIBED OVERDOSE 42 0.0022
817 EPILEPSY 66 0.0022
818 PULMONARY HYPERTENSION 44 0.0021
819 ATRIAL FIBRILLATION 205 0.0021
820 TACHYCARDIA 186 0.0021
821 HIP FRACTURE 67 0.0021
822 SYNCOPE 207 0.0021
823 RED BLOOD CELL COUNT DECREASED 59 0.0021
824 CONFUSIONAL STATE 333 0.0021
825 CORONARY ARTERY OCCLUSION 28 0.0020
826 URINARY RETENTION 68 0.0020
827 DRUG EFFECT INCOMPLETE 74 0.0020
828 BLOOD POTASSIUM INCREASED 33 0.0020
829 ARRHYTHMIA 96 0.0020
830 MENTAL STATUS CHANGES 56 0.0020
831 INJURY ASSOCIATED WITH DEVICE 41 0.0020
832 HYPOKINESIA 29 0.0020
833 HAEMOGLOBIN DECREASED 203 0.0020
834 ILL-DEFINED DISORDER 120 0.0020
835 DRUG ERUPTION 35 0.0020
836 HYPOKALAEMIA 91 0.0020
837 PARALYSIS 28 0.0020
838 HALLUCINATION, AUDITORY 31 0.0019
839 OXYGEN SATURATION DECREASED 109 0.0019
840 LIVER DISORDER 86 0.0019
841 FEMUR FRACTURE 60 0.0019
842 METRORRHAGIA 33 0.0019
843 ASPARTATE AMINOTRANSFERASE INCREASED 102 0.0019
844 CARDIAC FAILURE CONGESTIVE 154 0.0019
845 PYREXIA 663 0.0019
846 THERAPEUTIC RESPONSE DECREASED 116 0.0019
847 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 136 0.0019
848 HAEMATOCHEZIA 105 0.0019
849 DIABETES MELLITUS 145 0.0019
850 FRACTURE 36 0.0019
851 ABNORMAL BEHAVIOUR 75 0.0019
852 BRONCHOSPASM 27 0.0019
853 BONE DENSITY DECREASED 59 0.0019
854 EPISTAXIS 140 0.0019
855 BLOOD PRESSURE DECREASED 124 0.0019
856 INJURY 131 0.0019
857 LUNG DISORDER 91 0.0019
858 CORONARY ARTERY DISEASE 56 0.0018
859 BLINDNESS UNILATERAL 26 0.0018
860 COLITIS ULCERATIVE 82 0.0018
861 PREMATURE BABY 55 0.0018
862 THROMBOSIS 147 0.0018
863 PULMONARY FIBROSIS 35 0.0018
864 ADVERSE EVENT 168 0.0018
865 CIRCULATORY COLLAPSE 31 0.0018
866 SEIZURE 210 0.0018
867 CARDIAC DISORDER 169 0.0018
868 HYPOCALCAEMIA 34 0.0018
869 SEDATION 47 0.0018
870 LIVER INJURY 44 0.0018
871 WHITE BLOOD CELL COUNT DECREASED 194 0.0018
872 DRUG DOSE OMISSION 294 0.0018
873 AMENORRHOEA 31 0.0018
874 BLINDNESS 72 0.0018
875 RENAL DISORDER 82 0.0018
876 CARDIOMYOPATHY 26 0.0018
877 DEVICE RELATED INFECTION 27 0.0018
878 TRANSAMINASES INCREASED 39 0.0018
879 INCORRECT DRUG ADMINISTRATION DURATION 49 0.0017
880 COAGULOPATHY 29 0.0017
881 THERAPY PARTIAL RESPONDER 27 0.0017
882 GOUT 31 0.0017
883 ALANINE AMINOTRANSFERASE INCREASED 106 0.0017
884 ORTHOSTATIC HYPOTENSION 30 0.0017
885 HYPONATRAEMIA 97 0.0017
886 DRUG PRESCRIBING ERROR 33 0.0017
887 ACUTE RESPIRATORY FAILURE 33 0.0017
888 BLOOD COUNT ABNORMAL 26 0.0017
889 LEUKOCYTOSIS 31 0.0017
890 HALLUCINATION, VISUAL 36 0.0017
891 ANGIOEDEMA 75 0.0017
892 TOOTH LOSS 35 0.0017
893 HYPOTENSION 335 0.0017
894 ASCITES 49 0.0017
895 LABORATORY TEST ABNORMAL 49 0.0017
896 HEPATIC FAILURE 50 0.0017
897 PRODUCT PREPARATION ERROR 34 0.0017
898 ACNE 125 0.0016
899 CEREBROVASCULAR ACCIDENT 277 0.0016
900 INTENTIONAL SELF-INJURY 33 0.0016
901 MENORRHAGIA 32 0.0016
902 INJECTION SITE HAEMORRHAGE 130 0.0016
903 RASH MACULO-PAPULAR 36 0.0016
904 HAEMOPTYSIS 45 0.0016
905 SUICIDE ATTEMPT 97 0.0016
906 ANAEMIA 304 0.0016
907 PREGNANCY 31 0.0015
908 HAEMATOMA 40 0.0015
909 DIABETIC KETOACIDOSIS 37 0.0015
910 FULL BLOOD COUNT DECREASED 31 0.0015
911 RHABDOMYOLYSIS 64 0.0015
912 DRUG ADMINISTRATION ERROR 47 0.0015
913 CONVULSION 87 0.0015
914 PERICARDIAL EFFUSION 35 0.0015
915 OSTEONECROSIS OF JAW 37 0.0015
916 EXPOSURE DURING PREGNANCY 92 0.0015
917 HYPOXIA 52 0.0015
918 HAEMATEMESIS 37 0.0015
919 ACCIDENTAL EXPOSURE TO PRODUCT 150 0.0015
920 GAMMA-GLUTAMYLTRANSFERASE INCREASED 32 0.0014
921 PRODUCT STORAGE ERROR 125 0.0014
922 AGGRESSION 71 0.0014
923 VISUAL ACUITY REDUCED 47 0.0014
924 DEVICE LEAKAGE 61 0.0014
925 BLOOD BILIRUBIN INCREASED 38 0.0014
926 EMOTIONAL DISTRESS 168 0.0014
927 INTENTIONAL DRUG MISUSE 29 0.0014
928 ENCEPHALOPATHY 34 0.0014
929 DRUG WITHDRAWAL SYNDROME 119 0.0014
930 HEPATITIS 34 0.0013
931 PALLOR 36 0.0013
932 BLOOD CREATINE PHOSPHOKINASE INCREASED 38 0.0013
933 PULMONARY OEDEMA 59 0.0013
934 HYPERGLYCAEMIA 48 0.0013
935 UNRESPONSIVE TO STIMULI 33 0.0013
936 RENAL FAILURE ACUTE 54 0.0013
937 BLOOD GLUCOSE DECREASED 61 0.0013
938 RENAL IMPAIRMENT 106 0.0013
939 PLEURAL EFFUSION 76 0.0012
940 BRADYCARDIA 66 0.0012
941 GENERAL PHYSICAL HEALTH DETERIORATION 143 0.0012
942 NEOPLASM MALIGNANT 82 0.0012
943 BLOOD CREATININE INCREASED 79 0.0012
944 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 35 0.0012
945 PLATELET COUNT DECREASED 126 0.0012
946 ACCIDENTAL OVERDOSE 43 0.0012
947 HYPOGLYCAEMIA 57 0.0012
948 DRUG DOSE OMISSION BY DEVICE 92 0.0012
949 DELIRIUM 40 0.0012
950 BLOOD GLUCOSE INCREASED 213 0.0011
951 MYOCARDIAL INFARCTION 197 0.0011
952 LEUKOPENIA 55 0.0011
953 TARDIVE DYSKINESIA 31 0.0011
954 HOSPITALISATION 167 0.0011
955 EXTRA DOSE ADMINISTERED 44 0.0011
956 DEMENTIA 30 0.0011
957 TOXICITY TO VARIOUS AGENTS 181 0.0011
958 SEPSIS 119 0.0011
959 FOETAL EXPOSURE DURING PREGNANCY 86 0.0011
960 HAEMATURIA 36 0.0011
961 MENSTRUATION IRREGULAR 28 0.0010
962 COMPLETED SUICIDE 82 0.0010
963 METABOLIC ACIDOSIS 31 0.0010
964 GASTROINTESTINAL HAEMORRHAGE 81 0.0010
965 OSTEONECROSIS 31 0.0009
966 SEPTIC SHOCK 41 0.0009
967 PLASMA CELL MYELOMA 36 0.0009
968 ACUTE MYOCARDIAL INFARCTION 26 0.0009
969 OVERDOSE 189 0.0009
970 DEVICE USE ERROR 30 0.0009
971 NEUTROPHIL COUNT DECREASED 35 0.0009
972 COMA 40 0.0008
973 INTERSTITIAL LUNG DISEASE 40 0.0008
974 THROMBOCYTOPENIA 92 0.0008
975 HYPERKALAEMIA 28 0.0008
976 RESPIRATORY FAILURE 58 0.0008
977 DISEASE PROGRESSION 92 0.0008
978 FEBRILE NEUTROPENIA 50 0.0008
979 PANCYTOPENIA 42 0.0008
980 CARDIO-RESPIRATORY ARREST 31 0.0007
981 CEREBRAL HAEMORRHAGE 26 0.0007
982 INTENTIONAL OVERDOSE 43 0.0007
983 NEUTROPENIA 91 0.0007
984 CARDIAC ARREST 46 0.0006
985 CARDIAC FAILURE 43 0.0005
986 DRUG ABUSE 43 0.0005
987 DRUG DEPENDENCE 67 0.0004
988 MALIGNANT NEOPLASM PROGRESSION 38 0.0004
989 DEATH 310 0.0004